What is the Kilitch Drugs (India) Ltd share price today?

The share price of NSE:KILITCH-BE on 01 Oct 2026 (as of 15:04:02 IST) is ₹211.

What is the NSE:KILITCH-BE 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:KILITCH-BE 52 week high low range shows a high of ₹232.5 and a low of ₹117.25.

What is the Kilitch Drugs (India) Ltd market cap?

As on 01 Oct 2026, Kilitch Drugs (India) Ltd market cap is ₹7501000000.

What is the shareholding pattern of Kilitch Drugs (India) Ltd Stock?

The shareholding pattern of Kilitch Drugs (India) Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.77% Foreign Institutional Investors (FII): 0.12% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 36.11% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Kilitch Drugs (India) Ltd?

The Price-to-Earnings (PE) ratio of Kilitch Drugs (India) Ltd is 24.9584, and the Price-to-Book (PB) ratio is 1.5966, as on 01 Oct 2026.

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

-1.75%

1 Week

+0.40%

1 Month

-13.52%

3 Month

+5.15%

6 Month

+26.28%

YTD

+15.44%

1 Year

+6.92%

5 Year

+133.39%

10 Year

+795.14%

Max

+207.26%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

200.20

High

209.89

215.51

267.90

About

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

No results found

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Financial overview

Peer Comparison

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Cash Flow

Consolidated

Standalone

₹

%

Fundamental Ratios

Consolidated

Standalone

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Shareholding summary

No data available

Promoters

—

FII

—

DII

—

MF

—

Others

—

Promoters

FII

DII

MF

Others

Quarterly

Yearly

No data available

Shareholding Pattern

Quarterly

Yearly

No results found

Bulk & block deals

No results found

Insider trading & SAST

No results found

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Registrars

Management

Details

BSE

NSE

ISIN

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

Corporate filings & documents

No corporate filings & documents found

Kilitch Drugs (India) Share Price

202.13-3.59 (-1.75%)

+6.92% past 1 Year

News

Saregama Reports Strong Second Quarter Revenue Growth Year On Year

Equity

SAREGAMA

4 Nov 2026

Saregama Reports Stronger Second Quarter EBITDA and Margin Expansion

Equity

SAREGAMA

4 Nov 2026

Saregama Q2 Consolidated Net Profit Rises 47.85 Percent Year on Year

Equity

SAREGAMA

4 Nov 2026

Sangam India Reports Strong Second Quarter Revenue Growth

Equity

SANGAMIND

4 Nov 2026

Sangam India Reports Strong Second Quarter EBITDA Growth And Margin Expansion

Equity

SANGAMIND

4 Nov 2026

Sangam India Reports Strong Second Quarter Net Profit Growth

Equity

SANGAMIND

4 Nov 2026

Cera Sanitaryware Reports Higher Second Quarter EBITDA Despite Margin Compression

Equity

CERA

4 Nov 2026

Cera Sanitaryware Reports Strong Second Quarter Revenue Growth

Equity

CERA

4 Nov 2026

Cera Sanitaryware Reports Marginal Year On Year Decline In Second Quarter Profit

Equity

CERA

4 Nov 2026

Zydus Lifesciences Reports Lower EBITDA Margin Despite Yearly EBITDA Growth

Equity

ZYDUSLIFE

4 Nov 2026

Zydus Lifesciences Reports Strong Second Quarter Revenue Growth

Equity

ZYDUSLIFE

4 Nov 2026

Zydus Lifesciences Q2 Net Profit Falls Despite Beating Street Estimate

Equity

ZYDUSLIFE

4 Nov 2026

Ecoreco Reports Stronger Second Quarter EBITDA And Margin Growth

Equity

ECORECO

4 Nov 2026

Ecoreco Reports Stronger Second Quarter Revenue and Net Profit Growth

Equity

ECORECO

4 Nov 2026

Vijaya Diagnostic Raises FY27 EBITDA Margin Guidance To 42 Percent

Equity

VIJAYA

4 Nov 2026

BASF India Reports Strong Second Quarter Revenue Growth

Equity

BASF

4 Nov 2026

BASF India Reports Sharp Year On Year EBITDA Decline In Second Quarter

Equity

BASF

4 Nov 2026

BASF India Reports Sharp Year On Year Decline In Second Quarter Net Profit

Equity

BASF

4 Nov 2026

Prince Pipes Confirms Double Digit Growth And Operating Margin Outlook

Equity

PRINCEPIPE

4 Nov 2026

Aarti Drugs Cuts FY27 Volume Growth Guidance Amid Rising API Prices

Equity

AARTIDRUGS

4 Nov 2026

Kilitch Drugs (India) Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Kilitch Drugs (India) Share Price

Kilitch Drugs (India) Share Price

Financial overview

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Kilitch Drugs (India) Share Price

Kilitch Drugs (India) Share Price

Kilitch Drugs (India) Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Kilitch Drugs (India) Share Price

Corporate Actions

Company details

Kilitch Drugs (India) Share Price

Corporate filings & documents

Kilitch Drugs (India) Share Price

News

Saregama Reports Strong Second Quarter Revenue Growth Year On Year

Saregama Reports Stronger Second Quarter EBITDA and Margin Expansion

Saregama Q2 Consolidated Net Profit Rises 47.85 Percent Year on Year

Sangam India Reports Strong Second Quarter Revenue Growth

Sangam India Reports Strong Second Quarter EBITDA Growth And Margin Expansion

Sangam India Reports Strong Second Quarter Net Profit Growth

Cera Sanitaryware Reports Higher Second Quarter EBITDA Despite Margin Compression

Cera Sanitaryware Reports Strong Second Quarter Revenue Growth

Cera Sanitaryware Reports Marginal Year On Year Decline In Second Quarter Profit

Zydus Lifesciences Reports Lower EBITDA Margin Despite Yearly EBITDA Growth

Zydus Lifesciences Reports Strong Second Quarter Revenue Growth

Zydus Lifesciences Q2 Net Profit Falls Despite Beating Street Estimate

Ecoreco Reports Stronger Second Quarter EBITDA And Margin Growth

Ecoreco Reports Stronger Second Quarter Revenue and Net Profit Growth

Vijaya Diagnostic Raises FY27 EBITDA Margin Guidance To 42 Percent

BASF India Reports Strong Second Quarter Revenue Growth

BASF India Reports Sharp Year On Year EBITDA Decline In Second Quarter

BASF India Reports Sharp Year On Year Decline In Second Quarter Net Profit

Prince Pipes Confirms Double Digit Growth And Operating Margin Outlook

Aarti Drugs Cuts FY27 Volume Growth Guidance Amid Rising API Prices

Kilitch Drugs (India) Ltd Share Price Today

Kilitch Drugs (India) Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator